SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004699
Filing Date
2015-05-28
Accepted
2015-05-28 16:50:03
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20150331.htm 10-Q 1532091
2 EX-31.1 adro-ex311_201503316.htm EX-31.1 11761
3 EX-31.2 adro-ex312_201503317.htm EX-31.2 11726
4 EX-32.1 adro-ex321_201503318.htm EX-32.1 5412
5 EX-32.2 adro-ex322_201503319.htm EX-32.2 5370
  Complete submission text file 0001564590-15-004699.txt   6693085

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adro-20150331.xml EX-101.INS 992826
7 XBRL TAXONOMY EXTENSION SCHEMA adro-20150331.xsd EX-101.SCH 38693
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20150331_cal.xml EX-101.CAL 30631
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20150331_def.xml EX-101.DEF 129354
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20150331_lab.xml EX-101.LAB 301696
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20150331_pre.xml EX-101.PRE 247433
Mailing Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710
Business Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 15896039
SIC: 2834 Pharmaceutical Preparations